My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 172

    1.

    Systemic hypertension and glaucoma: mechanisms in common and co-occurrence.

    Langman MJ, Lancashire RJ, Cheng KK, Stewart PM.

    Br J Ophthalmol. 2005 Aug;89(8):960-3.PMID: 16024843 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Clinical evaluation of the effectiveness of combined use of local and general hypotensive agents in patients with glaucoma and hypertension]

    Zakharova IA, Makhmutov VIu, Pristavka VA, Kul'kova SV.

    Vestn Oftalmol. 2002 Jan-Feb;118(1):44-6. Russian. PMID: 11898362 [PubMed - indexed for MEDLINE]Related articles

    3.

    Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.

    Rejnmark L, Vestergaard P, Mosekilde L.

    J Hypertens. 2006 Mar;24(3):581-9.PMID: 16467662 [PubMed - indexed for MEDLINE]Related articles

    4.

    Systemic antihypertensive medication and incident open-angle glaucoma.

    Müskens RP, de Voogd S, Wolfs RC, Witteman JC, Hofman A, de Jong PT, Stricker BH, Jansonius NM.

    Ophthalmology. 2007 Dec;114(12):2221-6. Epub 2007 Jun 12.PMID: 17568677 [PubMed - indexed for MEDLINE]Related articles

    5.

    Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.

    Bourgault C, Elstein E, Baltzan MA, Le Lorier J, Suissa S.

    Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):287-94.PMID: 11760488 [PubMed - indexed for MEDLINE]Related articles

    6.

    Long-term effects of antihypertensive drugs on the risk of new-onset diabetes in elderly Taiwanese hypertensives.

    Liou YS, Ma T, Tien L, Chien C, Chou P, Jong GP.

    Int Heart J. 2008 Mar;49(2):205-11.PMID: 18475020 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.

    Van Wijk BL, Klungel OH, Heerdink ER, de Boer A.

    Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):587-93.PMID: 16586465 [PubMed - indexed for MEDLINE]Related articles

    8.

    Rate and determinants of 10-year persistence with antihypertensive drugs.

    Van Wijk BL, Klungel OH, Heerdink ER, de Boer A.

    J Hypertens. 2005 Nov;23(11):2101-7.PMID: 16208154 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.

    Burke TA, Sturkenboom MC, Ohman-Strickland PA, Wentworth CE, Rhoads GG.

    Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):979-87.PMID: 17605137 [PubMed - indexed for MEDLINE]Related articles

    10.

    Drug therapy for hypertension in hemodialysis patients.

    Hörl MP, Tepel M.

    Minerva Med. 2005 Aug;96(4):277-85. Review.PMID: 16179894 [PubMed - indexed for MEDLINE]Related articles

    11.

    Calcium-channel blockers and risk of cancer.

    Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR.

    Lancet. 1997 Feb 22;349(9051):525-8.PMID: 9048789 [PubMed - indexed for MEDLINE]Related articles

    12.

    Use of beta-blockers and risk of fractures.

    Schlienger RG, Kraenzlin ME, Jick SS, Meier CR.

    JAMA. 2004 Sep 15;292(11):1326-32.PMID: 15367554 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.

    Kuti EL, Baker WL, White CM.

    Curr Med Res Opin. 2007 Jun;23(6):1239-44. Epub 2007 Apr 23.PMID: 17559720 [PubMed - indexed for MEDLINE]Related articles

    14.

    Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.

    Burke TA, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG.

    J Hypertens. 2006 Jun;24(6):1193-200.PMID: 16685222 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies.

    Wiens M, Etminan M, Gill SS, Takkouche B.

    J Intern Med. 2006 Oct;260(4):350-62. Review.PMID: 16961672 [PubMed - indexed for MEDLINE]Related articles

    16.

    Difference in the occurrence of cardiovascular events according to class of antihypertensive agent, based on a follow-up study of Japanese hypertension patients.

    Uchiyama M, Kondo T, Tsuzuki Y, Zhu S, Tamakoshi K, Sakakibara H, Uchiyama S, Toyoshima H.

    Jpn Heart J. 2001 Sep;42(5):585-95.PMID: 11804300 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cardiovascular drugs and the risk of suicide: a nested case-control study.

    Callréus T, Agerskov Andersen U, Hallas J, Andersen M.

    Eur J Clin Pharmacol. 2007 Jun;63(6):591-6. Epub 2007 Mar 20.PMID: 17468865 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Sex-specific antihypertensive drug therapy]

    Pühringer P, Gouya G, Reichardt B, Wolzt M.

    Wien Med Wochenschr. 2006 Sep;156(17-18):498-500. German. PMID: 17041806 [PubMed - indexed for MEDLINE]Related articles

    19.

    Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.

    Sauer WH, Baer JT, Berlin JA, Kimmel SE.

    Am J Cardiol. 2004 Nov 1;94(9):1171-3.PMID: 15518614 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cardiovascular drug prescriptions and risk of depression in diabetic patients.

    Rathmann W, Haastert B, Roseman JM, Giani G.

    J Clin Epidemiol. 1999 Nov;52(11):1103-9.PMID: 10527005 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity